Acorn Capital Advisors »

Athira Pharma shares owned by Acorn Capital Advisors

Quarter-by-quarter ownership of Athira Pharma shares owned by Acorn Capital Advisors from 13F filings

Historical chart of Acorn Capital Advisors investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Acorn Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Acorn Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8M 502k 7.57

More positions owned by Acorn Capital Advisors

Terns Pharmaceuticals (TERN)
Cg Oncology (CGON)
Urogen Pharma (URGN)
Trevi Therapeutics (TRVI)
Puma Biotechnology (PBYI)
Candel Therapeutics (CADL)
Cybin Com New (HELP)
Verastem (VSTM)
Bicara Therapeutics (BCAX)
Protara Therapeutics Com Stk (TARA)
Onkure Therapeutics Class A Com (OKUR)
Cardiff Oncology (CRDF)
Athira Pharma Common Stock
Jasper Therapeuritc (JSPR)
Aura Biosciences (AURA)

View all positions for Acorn Capital Advisors

Top funds holding Athira Pharma

Perceptive Advisors
Acorn Capital Advisors
TCG Crossover Management
Commodore Capital
NEA Management Company
ADAR1 Capital Management
Vanguard Group
Propel Bio Management
Simplify Asset Management
Seven Fleet Capital Management
Renaissance Technologies
Pathstone Holdings
BlackRock
Acadian Asset Management
Citadel Advisors

View all funds holding Athira Pharma